Late recurrent testicular seminoma: histological evidence is required

Oncol Res Treat. 2015;38(6):286-8. doi: 10.1159/000430794. Epub 2015 May 19.

Abstract

Introduction: Over the past 3 decades, the appropriate management of metastatic germ cell tumours (GCT) has been defined by several phase III trials. Many follow-up recommendations have been published based on expert consensus. However, common clinical scenarios can still be vexing for clinicians who are less experienced at managing patients with testicular cancer.

Case report: We highlight the arduous diagnostic work-up of a suspected late relapsing metastatic GCT in a patient suffering from fatigue, weight loss and prominent retroperitoneal lymph nodes, 4 years after first-line chemotherapy for metastatic seminoma. The various explorations finally led to the diagnosis of Whipple's disease.

Conclusion: This unusual clinical case strongly highlights the need to perform an exhaustive evaluation, with a biopsy, if a late recurrent GCT is suspected to avoid pointless and potentially harmful treatment.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biopsy
  • Histiocytes / microbiology
  • Humans
  • Laparoscopy / methods
  • Lymph Nodes / microbiology
  • Male
  • Mesentery
  • Neoplasm Recurrence, Local / pathology*
  • Polymerase Chain Reaction
  • Saliva / microbiology
  • Seminoma / pathology*
  • Testicular Neoplasms / pathology*
  • Tropheryma / isolation & purification*
  • Whipple Disease / diagnosis*